Home Finance Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares
Finance

Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares

Share
Tenax Therapeutics CEO Christopher Giordano acquires ,087 in shares
Share


Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares

Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *